THE US Food and Drug
Administration has announced the
voluntary recall by Actavis Inc of 18
lots of its Fentanyl Transdermal
System 25mcg/hour C-II patches.
The move follows identification of
one lot shipped to market
containing a patch which released
its active ingredient faster than the
approved specification.
The recalled lots all have an
expiry date of Mar or Apr 2012,
and Fentanyl patches sold by
Actavis in Europe aren’t affected.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Oct 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Oct 10
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.